Sartorius has completed the acquisition of selected life science businesses of Danaher Corp. for $825 million, expanding its market position in bioanalytics as well as key areas of the manufacture of biopharmaceuticals. The acquired businesses, which become two divisions of the Sartorius Group, generated revenue of approximately $170 million in 2019 and cover various lab and bioprocessing technologies.   The FortéBio business for label-free biomolecular characterization includes protein ana...